Market Place
Sourcing Support
All News #Library
Quality
Seagen warns investors against TRC Capital’s latest `mini-tender offer
05 Mar 2021 //
ENDPTS
FDA approves first-line treatment for peripheral T-cell lymphoma
16 Nov 2018 //
FDA
US FDA lifts hold on Seattle Genetics` blood cancer ADC candidate
07 Mar 2017 //
IN PHARMATECHNOLOGIST
Seattle Genetics to resume trials as FDA lifts clinical hold
06 Mar 2017 //
REUTERS
FDA expands use of Seattle Genetics` lymphoma drug
17 Aug 2015 //
PHARMATIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.